BlackRock Fund Advisors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $319K | Buy |
104,579
+7,228
| +7% | +$22K | ﹤0.01% | 3320 |
|
2016
Q3 | $265K | Buy |
97,351
+17,654
| +22% | +$48.1K | ﹤0.01% | 3362 |
|
2016
Q2 | $228K | Sell |
79,697
-791,043
| -91% | -$2.26M | ﹤0.01% | 3406 |
|
2016
Q1 | $2.63M | Buy |
870,740
+381
| +0% | +$1.15K | ﹤0.01% | 2996 |
|
2015
Q4 | $3.02M | Buy |
870,359
+27,802
| +3% | +$96.5K | ﹤0.01% | 3039 |
|
2015
Q3 | $3.19M | Sell |
842,557
-10,041
| -1% | -$38K | ﹤0.01% | 2997 |
|
2015
Q2 | $4.86M | Buy |
852,598
+776,018
| +1,013% | +$4.42M | ﹤0.01% | 2938 |
|
2015
Q1 | $446K | Sell |
76,580
-5,184
| -6% | -$30.2K | ﹤0.01% | 3287 |
|
2014
Q4 | $464K | Buy |
81,764
+5,832
| +8% | +$33.1K | ﹤0.01% | 3280 |
|
2014
Q3 | $311K | Sell |
75,932
-5,512
| -7% | -$22.6K | ﹤0.01% | 3316 |
|
2014
Q2 | $371K | Sell |
81,444
-652,125
| -89% | -$2.97M | ﹤0.01% | 3273 |
|
2014
Q1 | $3.48M | Buy |
733,569
+29,764
| +4% | +$141K | ﹤0.01% | 3008 |
|
2013
Q4 | $3.31M | Sell |
703,805
-279,943
| -28% | -$1.32M | ﹤0.01% | 3028 |
|
2013
Q3 | $3.92M | Buy |
983,748
+93,926
| +11% | +$375K | ﹤0.01% | 2957 |
|
2013
Q2 | $3.17M | Buy |
+889,822
| New | +$3.17M | ﹤0.01% | 2958 |
|